# Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)

> **NCT01437111** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 200 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet

## Key facts

- **NCT ID:** NCT01437111
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-26
- **Primary completion:** 2012-12-05
- **Final completion:** 2012-12-05
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437111, "Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01437111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*